Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7393 p344
25 March 2006

This article
Reprint   Photocopy

PDF 50K, Acrobat Reader

Letters

· EPS
· Public health
· Supervision
· Assisted dying
· Paracetamol
· FDCs
· Branded prescribing
· Methadone mixture
· Incontinence products
· CPD
· The Society (2)


Letters to the Editor

Public health

Pharmacists have the chance to make a difference

From Dr B. P. Curwain, MRPharmS

I loved Chris Brewer’s Broad spectrum piece on why coronary prevention is a gamble (PJ, 11 March, p290). For a while now I have been explaining to GPs that, when a patient asks if a statin will stop them having a heart attack, the correct answer is: “Yes, if you are the lucky one out of the last 35 patients I have prescribed this drug for, otherwise no.”

Contrast this with the effects of lifestyle interventions. As Bandolier1 pointed out, if we can deal with smoking, weight, diet and lack of exercise we can massively reduce heart disease and strokes, and probably cancer, bone disorders, arthritis, depression and erectile dysfunction.

It is commonly thought that lifestyle interventions do not work. They do, if you do them, and they are more effective than medicines. It is not easy, but in the New Forest area, our smoking cessation service is currently recording a 90 per cent success rate after four weeks. Some of these patients will relapse but, nevertheless, this is impressive.

Similarly, there are successful interventions for those wishing to lose weight (most of us) and take more exercise. Dietary advice and prescriptions for exercise do not have to be a punishment for the overweight.

Pharmacists are being encouraged to develop their public health role. There are significant opportunities for both community and primary care trust-based pharmacists here. In fact, both groups should be working together. As well as coming up with suitable services, we must be prepared to evaluate them and, thus, add to the evidence base. Of course, medicines and advice about medicines will continue to be the core business of pharmacy but, with the NHS short of funds and looking for services which genuinely add value, things which demonstrably improve health will receive support.

Practice-based commissioning has significant incentives to develop services aimed at enhancing health and reducing the need for hospital and other health care. Traditionally, public health workers have been great at measuring the health of the population but have been less successful in improving it. With a workforce inside the NHS, plus the large network of publicly accessible premises, pharmacists have the chance to move this agenda on significantly. We need to work in partnership with other bodies and individuals. It does not have to be the pharmacist who personally delivers all these services, but it could form a significant plank in the development of community-based health care services.

Brian Curwain
Council election candidate
Royal Pharmaceutical Society


Reference

1. Healthy lifestyle for the few. Bandolier 2005;136:4.

Send your letter to The Editor

Previous Topic (Electronic prescription service)
Next Topic (Supervision)

Back to Top


©The Pharmaceutical Journal